Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The Chautauqua Funds underperformed their benchmarks in Q3 2025 due to weak stock selection in Tech and Financials, leading managers to rotate capital from trimmed giants like Alphabet and Mastercard into high-conviction holdings like Novo Nordisk and Genmab.
Full Quick Take
The Chautauqua Funds underperformed their benchmarks in Q3 2025 due to weak stock selection in Tech and Financials, leading managers to rotate capital from trimmed giants like Alphabet and Mastercard into high-conviction holdings like Novo Nordisk and Genmab.
